BioAffinity Technologies Shares Are Trading Lower After the Company Announced Pricing of a $2.5 Million Registered Direct Offering and a Concurrent Private Placement
BioAffinity Technologies宣布了250万美元的注册直接发行和并行私募的定价后,该公司股价走低
BioAffinity Technologies Shares Are Trading Lower After the Company Announced Pricing of a $2.5 Million Registered Direct Offering and a Concurrent Private Placement
BioAffinity Technologies宣布了250万美元的注册直接发行和并行私募的定价后,该公司股价走低
使用浏览器的分享功能,分享给你的好友吧